Effectiveness of Cannabis in the Treatment of Tinnitus Patients
NCT01969474 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2016-12-28
Summary
The hypothesis of the study is that the use of Cannabis will attenuate the tinnitus level as experienced by the patients.
Conditions
- Tinnitus
Interventions
Sponsors & Collaborators
-
Wolfson Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2016-12-31
Countries
- Israel
Study Locations
More Related Trials
-
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
NCT01749098 ·Status: COMPLETED ·Phase: PHASE1
-
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
NCT00588731 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
NCT01983267 ·Status: COMPLETED ·Phase: NA
-
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
NCT00690170 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Delta-9-THC and Iomazenil in Healthy Humans
NCT00982982 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome
NCT05115318 ·Status: COMPLETED
-
Psychopharmacology of Psilocybin in Cancer Patients
NCT00465595 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
NCT01382433 ·Status: UNKNOWN ·Phase: NA
-
Cannabidiol Treatment in Patients With Early Psychosis
NCT02504151 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia
NCT03189810 ·Status: COMPLETED ·Phase: NA
-
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
NCT07001878 ·Status: RECRUITING ·Phase: PHASE4
-
A Clinical Trial on the Antipsychotic Properties of Cannabidiol
NCT00309413 ·Status: COMPLETED ·Phase: PHASE2
-
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
NCT06058702 ·Status: RECRUITING ·Phase: PHASE1
-
The Effects of Nicotine on Cognition in Schizophrenia
NCT00383747 ·Status: COMPLETED ·Phase: PHASE4
-
MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva
NCT05432206 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia
NCT04700930 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
NCT00628290 ·Status: COMPLETED ·Phase: PHASE2
-
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
NCT06225232 ·Status: RECRUITING ·Phase: PHASE2
-
Ginkgo Biloba Extract in the Treatment of Schizophrenia
NCT05258123 ·Status: COMPLETED ·Phase: NA
-
Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia
NCT01292577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
NCT00169039 ·Status: TERMINATED ·Phase: PHASE4
-
A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
NCT02088060 ·Status: TERMINATED ·Phase: PHASE2
-
The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis
NCT01565174 ·Status: UNKNOWN
-
Efficacy and Tolerance of Cannabidiol in Patients with Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study
NCT06435299 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
NCT01213524 ·Status: COMPLETED ·Phase: PHASE2